CD274 and neoplasm: Metabolic reprogramming of the tumor microenvironment using nanoparticles has been reported to promote T-cell tumoricidal activity and decrease the expression of immuno-inhibitory molecules, such as PD-L1 [51], supporting this as a potential mechanism of PLA immune modulation.